Readmissions Reduction Program: Mortality and Readmissions for Chronic Obstructive Pulmonary Disease.

Area of Science:

• Health Services Research
• Pulmonology
• Public Health Policy

Background:

• The Hospital Readmissions Reduction Program (HRRP) aimed to decrease 30-day hospital readmissions for Medicare beneficiaries.
• The impact of HRRP on post-discharge mortality for patients with Chronic Obstructive Pulmonary Disease (COPD) remains unclear.

Purpose of the Study:

• To investigate the association between HRRP implementation and 30-day readmission rates.
• To assess the relationship between HRRP and 30-day post-discharge mortality in COPD patients.

Main Methods:

• Retrospective cohort study analyzing Medicare fee-for-service data (2006-2017).
• Included over 4.5 million admissions for beneficiaries aged 65+ with COPD.
• Data analyzed across three periods: pre-announcement, announcement, and implementation of HRRP.

Main Results:

• 30-day COPD readmission rates decreased from 20.54% to 18.74% during the HRRP implementation period.
• 30-day post-discharge mortality rates were 6.91% (pre-announcement), 6.59% (announcement), and 7.30% (implementation).
• HRRP implementation was linked to an estimated 1,196 to 3,858 additional deaths.

Conclusions:

• HRRP successfully reduced 30-day all-cause readmissions for COPD patients.
• HRRP implementation was associated with a significant increase in 30-day post-discharge mortality.
• Further investigation is required to confirm findings and identify factors driving increased mortality.